Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Non-coding RNA methylation modifications in ovarian cancer
Siyun Deng1, Ziyi Guo1, Shaojia Wang2
1Lab for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, 381 Nanchen Road, Shanghai 200444, China.
Abstract:
Ovarian cancer (OC) is a highly heterogeneous gynecological cancer with high mortality rates. Non-coding RNA is a class of transcripts which do not encode proteins, but plays important regulatory roles in gene expression and protein function by targeting specific genes or interacting with proteins. RNA methylation, mainly focused on m6A, m1A, m5C, and m7G, is a common post-transcriptional modification that is essential for regulating various biological processes, such as RNA transcription, splicing, structure, stability, and translation, and has been reported to be involved in the regulation of the development of various human malignancies. Recent scholarly inquiries have posited that methylation alterations occur on ncRNAs, implicating their involvement in the etiology of ovarian cancer. In this review, we summarized four common types of RNA methylation modifications and their associated enzymes, as well as methylated ncRNAs involved in regulating ovarian cancer. We briefly introduced the mechanisms of action of ncRNA methylation in the occurrence, proliferation, immune response, and drug resistance of ovarian cancer as reported currently, and the methylation-related lncRNAs that can be further studied.
Insights
RNA methylation, a key process in gene regulation, is increasingly linked to ovarian cancer (OC) development. This review explores how methylated non-coding RNAs (ncRNAs) influence OC progression and treatment resistance.
Area of Science:
- Molecular Biology
- Oncology
- Epigenetics
Background:
- Ovarian cancer (OC) is a heterogeneous gynecological malignancy with high mortality.
- Non-coding RNAs (ncRNAs) regulate gene expression and protein function.
- RNA methylation (m6A, m1A, m5C, m7G) is a crucial post-transcriptional modification involved in various biological processes and cancer development.
Purpose of the Study:
- To review common RNA methylation modifications and their associated enzymes.
- To summarize methylated ncRNAs implicated in ovarian cancer regulation.
- To explore the mechanisms of ncRNA methylation in OC occurrence, proliferation, immune response, and drug resistance.
Main Methods:
- Literature review of scholarly inquiries on RNA methylation and ovarian cancer.
- Summary of four common RNA methylation types and their enzymes.
- Analysis of current reports on ncRNA methylation's role in OC.
Main Results:
- Methylation alterations in ncRNAs are implicated in the etiology of ovarian cancer.
- ncRNA methylation influences OC occurrence, proliferation, immune response, and drug resistance.
- Specific methylation-related long non-coding RNAs (lncRNAs) show potential for further study.
Conclusions:
- RNA methylation, particularly in ncRNAs, plays a significant role in ovarian cancer pathogenesis.
- Understanding ncRNA methylation mechanisms offers insights into OC development and treatment.
- Methylation-related lncRNAs represent promising targets for future research and therapeutic strategies in ovarian cancer.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
MicroRNAs
MicroRNAs
RNA Stability
The Nucleolus

